Free Trial

Lemonade (LMND) Stock Forecast & Price Target

Lemonade logo
$41.54 +3.44 (+9.03%)
(As of 12/20/2024 05:45 PM ET)

Lemonade - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
3
Hold
3
Buy
1

Based on 7 Wall Street analysts who have issued ratings for Lemonade in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 7 analysts, 3 have given a sell rating, 3 have given a hold rating, and 1 has given a buy rating for LMND.

Consensus Price Target

$30.43
-26.75% Downside
According to the 7 analysts' twelve-month price targets for Lemonade, the average price target is $30.43. The highest price target for LMND is $60.00, while the lowest price target for LMND is $14.00. The average price target represents a forecasted downside of -26.75% from the current price of $41.54.
Get the Latest News and Ratings for LMND and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lemonade and its competitors.

Sign Up

LMND Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$30.43$30.43$18.86$12.67
Forecasted Upside-26.75% Downside-38.27% Downside8.06% Upside-26.01% Downside
Consensus Rating
Reduce
Reduce
Reduce
Reduce

LMND Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LMND Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lemonade Stock vs. The Competition

TypeLemonadeFinance CompaniesS&P 500
Consensus Rating Score
1.71
2.50
2.51
Consensus RatingReduceHoldModerate Buy
Predicted Upside-26.75% Downside18.66% Upside14.53% Upside
News Sentiment Rating
Negative News

See Recent LMND News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/22/2024JMP Securities
2 of 5 stars
 Boost TargetMarket Outperform ➝ Market Outperform$40.00 ➝ $60.00+19.14%
11/21/2024BMO Capital Markets
4 of 5 stars
 Boost TargetUnderperform ➝ Underperform$13.00 ➝ $15.00-69.79%
11/21/2024Piper Sandler
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$25.00 ➝ $44.00-5.54%
11/20/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$23.00 ➝ $42.00+4.71%
11/7/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Mcjoynt-Griff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeMarket Perform ➝ Underperform$18.00 ➝ $21.00-28.27%
10/9/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$15.00 ➝ $14.00-12.39%
1/10/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$17.00-1.76%
12/1/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform
5/9/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$16.00 ➝ $17.00+4.55%
5/4/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$14.00 ➝ $12.00+8.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:51 AM ET.


LMND Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Lemonade is $30.43, with a high forecast of $60.00 and a low forecast of $14.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lemonade in the last year. There are currently 3 sell ratings, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" LMND shares.

According to analysts, Lemonade's stock has a predicted downside of -26.75% based on their 12-month stock forecasts.

Over the previous 90 days, Lemonade's stock had 1 upgrade and 1 downgrade by analysts.

Lemonade has been rated by research analysts at BMO Capital Markets, Jefferies Financial Group, JMP Securities, Keefe, Bruyette & Woods, Morgan Stanley, and Piper Sandler in the past 90 days.

Analysts like Lemonade less than other "finance" companies. The consensus rating for Lemonade is Reduce while the average consensus rating for "finance" companies is Hold. Learn more on how LMND compares to other companies.


This page (NYSE:LMND) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners